72 related articles for article (PubMed ID: 32695805)
1. A Novel Methylation-based Model for Prognostic Prediction in Lung Adenocarcinoma.
Li M; Deng X; Zhou D; Liu X; Dai J; Liu Q
Curr Genomics; 2024 Feb; 25(1):26-40. PubMed ID: 38544827
[TBL] [Abstract][Full Text] [Related]
2. Identification of a DNA-methylome-based signature for prognosis prediction in driver gene-negative lung adenocarcinoma.
Shu M; Huang L; Chen Y; Wang Y; Xie Z; Li S; Zhou J; Wei L; Fu T; Liu B; Chen H; Tang K; Ke Z
Cancer Lett; 2024 Jul; 593():216835. PubMed ID: 38548216
[TBL] [Abstract][Full Text] [Related]
3. Identification of a ferroptosis-related gene signature (FRGS) for predicting clinical outcome in lung adenocarcinoma.
Wang S; Wu C; Ma D; Hu Q
PeerJ; 2021; 9():e11233. PubMed ID: 33954048
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma.
Wu G; Wang Q; Zhu T; Fu L; Li Z; Wu Y; Zhang C
Front Genet; 2021; 12():681277. PubMed ID: 34306024
[TBL] [Abstract][Full Text] [Related]
5. Integrated multi-omics analysis for lung adenocarcinoma in Xuanwei, China.
Jiang B; Yang J; He R; Wang D; Huang Y; Zhao G; Ning M; Zeng T; Li G
Aging (Albany NY); 2023 Dec; 15(23):14263-14291. PubMed ID: 38095636
[TBL] [Abstract][Full Text] [Related]
6. Machine learning and bioinformatics analysis revealed classification and potential treatment strategy in stage 3-4 NSCLC patients.
Li C; Tian C; Zeng Y; Liang J; Yang Q; Gu F; Hu Y; Liu L
BMC Med Genomics; 2022 Feb; 15(1):33. PubMed ID: 35193578
[TBL] [Abstract][Full Text] [Related]
7. Identifying M1 Macrophage-Related Genes Through a Co-expression Network to Construct a Four-Gene Risk-Scoring Model for Predicting Thyroid Cancer Prognosis.
Zhuang G; Zeng Y; Tang Q; He Q; Luo G
Front Genet; 2020; 11():591079. PubMed ID: 33193731
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases.
Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S
Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836
[TBL] [Abstract][Full Text] [Related]
9. Identification of Prognostic Immune-Related Genes by Integrating mRNA Expression and Methylation in Lung Adenocarcinoma.
Zhu J; Wang M; Hu D
Int J Genomics; 2020; 2020():9548632. PubMed ID: 32695805
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
11. Development of an autophagy-related gene prognostic signature in lung adenocarcinoma and lung squamous cell carcinoma.
Zhu J; Wang M; Hu D
PeerJ; 2020; 8():e8288. PubMed ID: 31938577
[TBL] [Abstract][Full Text] [Related]
12. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
Chen D; Luo L; Liang C
PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of pyroptosis-related factors in lung adenocarcinoma.
Lin X; Zhou T; Hu S; Yang L; Yang Z; Pang H; Zhou X; Zhong R; Fang X; Yu Z; Hu K
J Thorac Dis; 2022 Mar; 14(3):654-667. PubMed ID: 35399245
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
